GSA Capital Partners’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,350
Closed -$409K 1998
2018
Q3
$409K Sell
6,350
-30,198
-83% -$1.84M 0.02% 1170
2018
Q2
$1.78M Buy
36,548
+12,030
+49% +$623K 0.09% 338
2018
Q1
$1.15M Buy
+24,518
New +$1.18M 0.06% 568
2017
Q4
Sell
-11,828
Closed -$685K 1998
2017
Q3
$685K Sell
11,828
-304
-3% -$18.1K 0.05% 755
2017
Q2
$815K Buy
+12,132
New +$767K 0.05% 709
2015
Q4
Sell
-14,740
Closed -$1.04M 2154
2015
Q3
$1.04M Buy
14,740
+1,240
+9% +$101K 0.05% 596
2015
Q2
$1.17M Sell
13,500
-11,272
-46% -$852K 0.05% 759
2015
Q1
$1.82M Buy
24,772
+19,257
+349% +$1.37M 0.07% 403
2014
Q4
$397K Sell
5,515
-25,169
-82% -$1.74M 0.03% 1094
2014
Q3
$2.12M Buy
30,684
+6,586
+27% +$463K 0.11% 180
2014
Q2
$1.5M Buy
24,098
+12,479
+107% +$732K 0.07% 418
2014
Q1
$634K Buy
+11,619
New +$621K 0.05% 617
2013
Q4
Sell
-10,958
Closed -$511K 1947
2013
Q3
$511K Buy
10,958
+3,850
+54% +$184K 0.04% 783
2013
Q2
$347K Buy
+7,108
New +$341K 0.04% 785

Other funds holding LPNT

GSA Capital Partners's LPNT Position: Q4 2018 in Review

GSA Capital Partners sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 6,350 shares — an estimated $409K sold.

GSA Capital Partners first reported a position in LPNT in Q2 2013 and held it in 14 quarters. The position peaked at $2.12M in Q3 2014. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • GSA Capital Partners reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • GSA Capital Partners sold 6,350 LifePoint Health, Inc. shares in Q4 2018, an estimated $409K.
  • GSA Capital Partners first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 14 quarters.
  • GSA Capital Partners's LifePoint Health, Inc. position peaked at $2.12M in Q3 2014.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on GSA Capital Partners's 13F filing for Q4 2018, filed 12 Feb 2019.